What Happened
The U.S. Attorney's Office in Boston announced in May 2024 a $25,000 settlement with Maida Pharmacy, Inc., an Arlington-based retail and compounding pharmacy, to resolve allegations that it failed to maintain adequate records of controlled substances and improperly disposed of them. Maida admitted that a DEA inspection found it lacked proper security protocols and appropriate records, that it had not conducted its mandatory inventory accountability audit, and that it failed to maintain an appropriate security system. It also admitted that employees on several occasions disposed of ketamine in the curbside trash rather than destroying it properly.
“its employees disposed of Ketamine by placing it in the curbside trash”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.